Перейти к основному содержанию
AkademIndex

Продукты

Для разработчиков

AkademBaseОткрытый API экосистемы
Статья

The Risk of Going Small

Tiffany WongDepartment of Surgery, Queen Mary Hospital, Hong Kong, ChinaJames FungDepartment of Medicine, Queen Mary Hospital, Hong Kong, ChinaTracy Yushi CuiDepartment of Surgery, Queen Mary Hospital, Hong Kong, ChinaSui‐Ling SinDepartment of Surgery, Queen Mary Hospital, Hong Kong, ChinaKettner Norman W.Department of Surgery, Queen Mary Hospital, Hong Kong, ChinaBrian SheDepartment of Surgery, Queen Mary Hospital, Hong Kong, ChinaAlbert ChanDepartment of Surgery, Queen Mary Hospital, Hong Kong, ChinaKsh ChokDepartment of Surgery, Queen Mary Hospital, Hong Kong, ChinaJeff DaiDepartment of Surgery, Queen Mary Hospital, Hong Kong, ChinaTan To CheungDepartment of Surgery, Queen Mary Hospital, Hong Kong, ChinaChung‐Mau LoDepartment of Surgery, Queen Mary Hospital, Hong Kong, China
2020en
ABI

Аннотация

Objective: The aim of this study was to determine the outcomes of living donor liver transplantation (LDLT) according to various graft-to-recipient weight ratio (GRWR). Background: The standard GRWR in LDLT is >0.8%. Our center accepted predicted GRWR ≥0.6% in selected patients. Methods: Data from patients who underwent LDLT from 2001 to 2017 were included. Patients were stratified according to actual GRWR (Group 1:GRWR ≤0.6%; Group 2: 0.6%<GRWR≤ 0.8%; Group 3:GRWR >0.8%). Results: There were 545 LDLT (group 1 = 39; group 2 = 159; group 3 = 347) performed. Pretransplant predicted GRWR showed good correlation to actual GRWR ( R 2 = 0.834) and these figures differed within a ± 10%margin ( P = 0.034) using an equivalence test. There were more left lobe grafts in group 1 (33.3%) than group 2 (10.7%) and 3 (2.9%). Median donor age was <35 years and steatosis >10% was rare. There was no difference in postoperative complication, vascular and biliary complication rate between groups. Over one-fifth (20.5%) of group 1 patients required portal flow modulation (PFM) and was higher than group 2 (3.1%) and group 3 (4%) ( P = 0.001). Twenty-six patients developed small-for-size syndrome (SFSS): 5 of 39 (12.8%) in group 1 and 21 of 159 (13.2%) in group 2 and none in group 3 ( P < 0.001). There were 2 hospital mortalities; otherwise, the remaining patients [24/26 (92.3%)] survive with a functional liver graft. The 5-year graft survival rates were 85.4% versus 87.8% versus 84.7% for group 1, 2, and 3, respectively ( P = 0.718). GRWR did not predict worse survivals in multivariable analysis. Conclusions: Graft size in LDLT can be lowered to 0.6% after careful recipient selection, with low incidence of SFSS and excellent outcomes. Accurate graft weight prediction, donor-recipient matching, meticulous surgical techniques, appropriate use of PFM, and vigilant perioperative care is important to the success of such approach.

Перевод пока недоступен

Идентификаторы

Цитирования и источники

Цитирований: 3Использованных источников: 0